Malignant Tumors
30
7
8
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
7%
2 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (30)
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Chinese Population Health and Multimorbidity Study
A Study of LM-350 in Subjects With Advanced Solid Tumours
PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors
125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the Treatment of Malignant Tumors
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
The Predictive Value of Serum Histone Succinylation in Malignant Solid Tumors
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
Study of LM-299 in Subjects Advanced Malignant Tumors
A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases
BBPA PET/CT in Patients With Malignant Tumors
Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET
Usefulness of Gadovist-enhanced FLAIR Imaging